ET124 treatment effectively increased microglial miR-124 levels and prevented alterations in their morphology, as well as in the expression of P2RY12, TREM2, HLA-DRA, and HMGB1. Such effects minimized the AD-related molecular signature and supported the preservation of neuroreparative and functional microglia. The gene discussed is HLA-DRA; the disease is Alzheimer disease.